↓ Skip to main content

Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden

Overview of attention for article published in Health Policy, November 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden
Published in
Health Policy, November 2011
DOI 10.1016/j.healthpol.2011.10.010
Pubmed ID
Authors

Billie Pettersson, Mikael Hoffmann, Per Wändell, Lars-Åke Levin

Abstract

A new reimbursement scheme (RS) for lipid modifying therapies (LMT) was implemented in Sweden in June 2009. Products on the market were continued, restricted or excluded in the new RS. The aim of this study was to compare utilization, costs and switching behavior in patients treated with LMT before and after the new RS.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 5%
Unknown 36 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 26%
Other 4 11%
Student > Postgraduate 4 11%
Student > Master 4 11%
Student > Ph. D. Student 2 5%
Other 3 8%
Unknown 11 29%
Readers by discipline Count As %
Medicine and Dentistry 9 24%
Pharmacology, Toxicology and Pharmaceutical Science 6 16%
Economics, Econometrics and Finance 4 11%
Business, Management and Accounting 3 8%
Agricultural and Biological Sciences 2 5%
Other 5 13%
Unknown 9 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2021.
All research outputs
#5,446,210
of 25,371,288 outputs
Outputs from Health Policy
#853
of 2,827 outputs
Outputs of similar age
#42,259
of 245,305 outputs
Outputs of similar age from Health Policy
#8
of 26 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,827 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,305 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.